[1] 陈志君.奥美拉唑联合法莫替丁治疗慢性胃炎137例[J].中国药
业,2012,21(11):86-87.
[2] Moon JY, Kim GH, You HS,et al. Levofloxacin,metro-nidazole,and lansoprazole triple therapy compared to qua-druple therapy as a second-line treatment of Helicobacter
pylori infection in Korea [J]. Gut Liver,2013,7(4):406.
[3] 中华医学会消化病学分会.中国慢性胃炎共识意见[J].胃肠病学,
2006,11(11):674-684.
[4] Liu KS, Hung IF, Seto WK, et al. Ten day sequential
versus 10 day modified bismuth quadruple therapy as em-pirical firstline and secondline treatment for Helicobacter
pylori in Chinese patients:an open label,randomized,cross-over trial [J]. Gut,2014,63(9):1410.
[5] 黄存根.胃苏颗粒联合三联疗法治疗Hp感染慢性胃炎的效果[J].
当代医学,2016,22(2):124-125.
[6] 张峰,王卫国,谢燕,等.慢性萎缩性胃炎胃镜与病理诊断的符合
率及与Hp感染的相关性分析[J].临床和实验医学杂志,2016,15
(23):2325-2327.
[7] 陶智,王梦旻,吕惠芳,等.3种用药方案治疗幽门螺杆菌感染活动
性慢性胃炎的临床观察[J].中国药房,2016,27(30):4224-4226
[8] 宋忠诚.3种用药方案治疗幽门螺杆菌感染活动性慢性胃炎的临
床疗效对比观察[J].饮食保健,2018,5(24):23-24.